Figure 4From: Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activityReceiver operating characteristic (ROC) analysis of DAS28 (disease activity score based on the 28-joint count) to predict withdrawal from treatment due to inefficacy.Back to article page